OraSure Technologies
NowDx Countersues OraSure in Ongoing Legal Battle Over Point-of-Care Trade Secrets
Following OraSure's November 2024 lawsuit accusing NowDx of misappropriating trade secrets, NowDx has countersued OraSure over similar allegations.
In Brief This Week: Hologic, Labcorp, Adaptive Biotechnologies, OraSure, Leica Biosystems
News items for the week of Jan. 6, 2025.
Top Five Articles on 360Dx Last Week: Sepsis Testing in 2024; Clinical Labs and FDA LDT Rule; More
Last week, readers were most interested in a story about the progress made by test developers toward commercializing rapid tests for sepsis.
360Dx Top 30 Rebounds in 2024, Rises 4 Percent
Of the 30 companies in the index, 16 saw their share prices rise, while 14 saw their share prices decline.
BARDA Awards OraSure Technologies, InBios International up to $27M
The awards will support the development of US Food and Drug Administration-cleared tests for Marburg virus and Burkholderia pseudomallei infection.